Biochemicals

Items 1-10 of 794

Page
per page
Set Descending Direction
  1. α-Galactosylceramide
    CAS  158021-47-7
    AG-CN2-0013
    AG-CN2-0013-C250250 µg
    CHF 130.00
    AG-CN2-0013-M0011 mg
    CHF 210.00
    AG-CN2-0013-M0055 mg
    CHF 840.00
    α-Galactosylceramide
  2. α-Galactosylceramide (Dansylated)
    CAS  424823-23-4
    AG-CN2-0514
    AG-CN2-0514-C500500 µg
    CHF 350.00
    AG-CN2-0514-M0011 mg
    CHF 590.00
    α-Galactosylceramide (Dansylated)
  3. α-Galactosylceramide Analog 8
    CAS  922727-14-8
    AG-CR1-3622
    AG-CR1-3622-C500500 µg
    CHF 290.00
    α-Galactosylceramide Analog 8
  4. α-Galactosylceramide Analog I (water soluble) [KBC-007]
    CAS  1037297-61-2
    AG-CR1-3608
    AG-CR1-3608-C100100 µg
    CHF 130.00
    α-Galactosylceramide Analog I (water soluble) [KBC-007]
  5. α-Mannosylceramide
    CAS  320610-63-7
    AG-CR1-3594
    AG-CR1-3594-C250250 µg
    CHF 180.00
    AG-CR1-3594-M0011 mg
    CHF 370.00
    α-Mannosylceramide
  6. α-NETA
    CAS  31059-54-8
    AG-CR1-0151
    AG-CR1-0151-M0055 mg
    CHF 60.00
    AG-CR1-0151-M02525 mg
    CHF 240.00
    α-NETA
  7. β-Mannosylceramide
    CAS  1334332-65-8
    AG-CR1-3621
    AG-CR1-3621-C250250 µg
    CHF 190.00
    AG-CR1-3621-M0011 mg
    CHF 390.00
    β-Mannosylceramide
  8. (±)-Verapamil . hydrochloride (USP Grade)
    CAS  152-11-4
    AG-CR1-3627
    AG-CR1-3627-M100100 mg
    CHF 35.00
    AG-CR1-3627-G0011 g
    CHF 45.00
    AG-CR1-3627-G0055 g
    CHF 135.00
    (±)-Verapamil . hydrochloride (USP Grade)
  9. (+)-Brefeldin A
    CAS  20350-15-6
    AG-CN2-0018
    AG-CN2-0018-M0055 mg
    CHF 40.00
    AG-CN2-0018-M01010 mg
    CHF 65.00
    AG-CN2-0018-M02525 mg
    CHF 130.00
    (+)-Brefeldin A
  10. (+)-Catechin . hydrate
    CAS  225937-10-0 or 88191-48-4
    AG-CN2-0407
    AG-CN2-0407-M500500 mg
    CHF 40.00
    AG-CN2-0407-G0011 g
    CHF 65.00
    (+)-Catechin . hydrate

Items 1-10 of 794

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.